Minerva Neurosciences, Inc. (NERV) Return on equity 2017–2021
Minerva Neurosciences, Inc. (NERV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-625.7%FY2021 · since FY2017: -24.0% → -625.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -625.7% | -629.4 pp |
| FY2020 | 3.7% | +263.5 pp |
| FY2019 | -259.8% | -204.3 pp |
| FY2018 | -55.6% | -31.6 pp |
| FY2017 | -24.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More NERV financial trends
NERV RevenueNERV Net incomeNERV Net marginNERV Gross profitNERV Gross marginNERV Operating incomeNERV Operating marginNERV Operating cash flowNERV Free cash flowNERV Capital expendituresNERV Stock buybacksNERV Dividends paidNERV Total assetsNERV Total liabilitiesNERV Shareholders’ equityNERV overview →